相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。New developments on the TNFα-mediated signalling pathways
Swaminathan Sethu et al.
BIOSCIENCE REPORTS (2011)
Rapid diagnosis of multidrug resistance in cancer by electrochemical sensor based on carbon nanotubes-drug supramolecular nanocomposites
Haijun Zhang et al.
BIOSENSORS & BIOELECTRONICS (2011)
H1, a novel derivative of tetrandrine reverse P-glycoprotein-mediated multidrug resistance by inhibiting transport function and expression of P-glycoprotein
Ning Wei et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
COX-2 contributes to P-glycoprotein-mediated multidrug resistance via phosphorylation of c-Jun at Ser63/73 in colorectal cancer
Hua Sui et al.
CARCINOGENESIS (2011)
Roles of cAMP and cAMP-dependent protein kinase in the progression of prostate cancer: Cross-talk with the androgen receptor
Dennis Merkle et al.
CELLULAR SIGNALLING (2011)
Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells
Yue Wang et al.
CYTOKINE (2011)
Variation of MDR Proteins Expression and Activity Levels According to Clinical Status and Evolution of CML Patients
Flavia C. Vasconcelos et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2011)
YC-1, a novel potential anticancer agent, inhibit multidrug-resistant protein via cGMP-dependent pathway
Chin-Chuan Hung et al.
INVESTIGATIONAL NEW DRUGS (2011)
PSC833, cyclosporine analogue, downregulates MDR1 expression by activating JNK/c-Jun/AP-1 and suppressing NF-κB
H. Bark et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Targeting the PI3K signaling pathway in cancer
Kwok-Kin Wong et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2010)
Suppression of the androgen receptor function by quercetin through protein-protein interactions of Sp1, c-Jun, and the androgen receptor in human prostate cancer cells
Huiqing Yuan et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
Multiple Drug Resistance Mechanisms in Cancer
Bruce C. Baguley
MOLECULAR BIOTECHNOLOGY (2010)
Molecular mechanism of suppression of MDR1 by puerarin from Pueraria lobata via NF-κB pathway and cAMP-responsive element transcriptional activity-dependent up-regulation of AMP-activated protein kinase in breast cancer MCF-7/adr cells
Tran Thi Hien et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2010)
MDR1 (C3435T) polymorphism: relation to the risk of breast cancer and therapeutic outcome
M. Cizmarikova et al.
PHARMACOGENOMICS JOURNAL (2010)
PTEN-mediated pathways and their association with treatment-resistant prostate cancer
Christopher C. Uzoh et al.
BJU INTERNATIONAL (2009)
Lipid dependence of ABC transporter localization and function
Karin Klappe et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2009)
Epac1-Induced Cellular Proliferation in Prostate Cancer Cells Is Mediated by B-Raf/ERK and mTOR Signaling Cascades
Uma Kant Misra et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
JWA Sensitizes P-Glycoprotein-Mediated Drug-Resistant Choriocarcinoma Cells to Etoposide VIA JNK and Mitochondrial-Associated Signal Pathway
Yan Zhang et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2009)
Different expression profiles of Y-box-binding protein-1 and multidrug resistance-associated proteins between alveolar and embryonal rhabdomyosarcoma
Yoshinao Oda et al.
CANCER SCIENCE (2008)
Calebin-A induces apoptosis and modulates MAPK family activity in drug resistant human gastric cancer cells
Yan Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
c-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemia
E. D. Lagadinou et al.
LEUKEMIA (2008)
Can celecoxib affect P-glycoprotein-mediated drug efflux? A microPET study
Erik F. J. De Vries et al.
NUCLEAR MEDICINE AND BIOLOGY (2008)
The role of PTEN signaling perturbations in cancer and in targeted therapy
M. Keniry et al.
ONCOGENE (2008)
PGE2 inhibits apoptosis in human adenocarcinoma Caco-2 cell line through Ras-PI3K association and cAMP-dependent kinase A activation
Vincenza Leone et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Regulation of MDR1 gene expression in multidrug-resistant cancer cells is independent from YB-1
Alexander Kaszubiak et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
NF-κB as a target for cancer therapy
Davide Melisi et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
A mitogen-activated protein kinase kinase kinase mediates reactive oxygen species homeostasis in Arabidopsis
Hirofumi Nakagami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Mechanisms and strategies to overcome multiple drug resistance in cancer
Tomris Ozben
FEBS LETTERS (2006)
The role of prostaglandin E receptor-dependent signaling via cAMP in mdr1b gene activation in primary rat hepatocyte cultures
C Ziemann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Differential effects of melatonin and its downstream effector PKCα on subcellular localization of RGS proteins
A Rimler et al.
JOURNAL OF PINEAL RESEARCH (2006)
Inhibition of NF-κB activity by BAY 11-7082 increases apoptosis in multidrug resistant leukemic T-cell lines
MG García et al.
LEUKEMIA RESEARCH (2005)
Sp transcription factor family and its role in cancer
S Safe et al.
EUROPEAN JOURNAL OF CANCER (2005)
Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line
S Lee et al.
GYNECOLOGIC ONCOLOGY (2005)
c-Jun NH2-terminal kinase activation contributes to hypoxia-inducible factor 1α-dependent P-glycoprotein expression in hypoxia
KM Comerford et al.
CANCER RESEARCH (2004)
Phosphatidylinositol 3′-kinase activation leads to multidrug resistance protein-1 expression and subsequent chemoresistance in advanced prostate cancer cells
JT Lee et al.
CANCER RESEARCH (2004)
Tumour necrosis factor α:: a potential target for the therapy of solid tumours
PW Szlosarek et al.
LANCET ONCOLOGY (2003)
Disulfiram-mediated inhibition of NF-κB activity enhances cytotoxicity of 5-fluorouracil in human colorectal cancer cell lines
WG Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-κB signaling
MT Kuo et al.
ONCOGENE (2002)
The JNK signal transduction pathway
CR Weston et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2002)
SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance
M Barancík et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2001)
The human ATP-binding cassette (ABC) transporter superfamily
M Dean et al.
GENOME RESEARCH (2001)
Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase γ
ME Pacold et al.
CELL (2000)
NF-κB-induced loss of MyoD messenger RNA:: Possible role in muscle decay and cachexia
DC Guttridge et al.
SCIENCE (2000)
分享论文
